Novartis AG said on Thursday it would sell the dermatology and generic US oral solids portfolios of Sandoz US to Aurobindo Pharma Ltd for $900 million, as the Swiss drug maker looks to focus on higher...
from NDTV Profit - Latest https://ift.tt/2M2AW7m
via IFTTT
Friday, September 7, 2018
Subscribe to:
Post Comments (Atom)
Hello, Forget my name. Important is I'm a 50 year old self-employed and I am doing my service for all.
No comments:
Post a Comment